Continuous single motor unit electromyographic activity in adefovir associated myopathy.
Lo
Y L
YL
See
S J
SJ
Tan
C K
CK
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000998:Antiviral Agents / Q000009:adverse effects*; D002908:Chronic Disease; D003402:Creatine Kinase / Q000097:blood; D004576:Electromyography; D006509:Hepatitis B / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D028361:Mitochondrial Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D018485:Muscle Fibers, Skeletal / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D009135:Muscular Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000187:drug effects / Q000378:metabolism; D063065:Organophosphonates / Q000009:adverse effects*; D028761:Withholding Treatment
D000998:Antiviral Agents; D063065:Organophosphonates; C053001:adefovir; D003402:Creatine Kinase; D000225:Adenine